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Abstract: Cancer stem cells (CSC) represent a key cellular subpopulation controlling biological
features such as cancer progression in all cancer types. By using melanospheres established
from human melanoma patients, we compared less differentiated melanosphere-derived CSC to
differentiating melanosphere-derived cells. Increased lipid uptake was found in melanosphere-derived
CSC vs. differentiating melanosphere-derived cells, paralleled by strong expression of lipogenic
factors Sterol Regulatory Element-Binding Protein-1 (SREBP-1) and Peroxisome Proliferator-Activated
Receptor-γ (PPAR-γ). An inverse relation between lipid-storing phenotype and autophagy was also
found, since microtubule-associated protein 1A/1B-Light Chain 3 (LC3) lipidation is reduced in
melanosphere-derived CSC. To investigate upstream autophagy regulators, Phospho-AMP activated
Protein Kinase (P-AMPK) and Phospho-mammalian Target of Rapamycin (P-mTOR) were analyzed;
lower P-AMPK and higher P-mTOR expression in melanosphere-derived CSC were found, thus
explaining, at least in part, their lower autophagic activity. In addition, co-localization of LC3-stained
autophagosome spots and perilipin-stained lipid droplets was demonstrated mainly in differentiating
melanosphere-derived cells, further supporting the role of autophagy in lipid droplets clearance.
The present manuscript demonstrates an inverse relationship between lipid-storing phenotype and
melanoma stem cells differentiation, providing novel indications involving autophagy in melanoma
stem cells biology.
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1. Introduction
Melanoma is one of the most aggressive cancers and it has an increasing incidence worldwide [1].
Similar to other tumors, melanoma contains cancer stem cells (CSC). Such cells are able to grow as
melanospheres making their isolation and indefinite growth from metastatic melanomas possible [2].
CSC represent the driving force within the tumor because they are able to produce all cell types found
in the original tumor and are responsible for metastatic dissemination [3]. CSC represent a relevant
therapeutic target since they are usually resistant to conventional chemotherapy and radiotherapy [4];
knowing in detail CSC biology is therefore crucial for planning effective therapeutic approaches.
Int. J. Mol. Sci. 2017, 18, 1271; doi:10.3390/ijms18061271 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2017, 18, 1271 2 of 12
For such reasons, signaling pathways specifically activated in CSC but not in the bulk tumor are
particularly relevant to identify novel therapeutically important targets.
Lipid levels within the cells appear to have a role in oncogenesis since inhibition of lipogenic
enzymes (such as fatty acid synthase and acetyl-CoA carboxylase) is able to counteract growth of
different tumors [5,6]. The link between altered lipid metabolism and oncogenesis is well accepted;
nevertheless, lipid-related differences between CSC and bulk cells in the tumor are still a poorly
investigated field. In melanoma, the metabolomic lipid profile of CSC may be different from the
corresponding profile of bulk tumor cells [7]. Furthermore, in colon cancer, prostate cancer and
melanoma, a correlation between high lipids content and metastatic potential was reported [8,9].
Few data are available regarding key molecular mechanisms underlying lipid accumulation. It is
well recognized that cancer cells display increased biosynthesis of lipids through de novo fatty-acid
synthesis, but little is known about additional mechanisms leading to the acquisition of a lipid-storing
phenotype. Such phenotype has been demonstrated in colorectal cancer where high levels of
lipid droplets (LD) correlate with CD133 antigen (also known as prominin-1) expression level
and Wingless-type MMTV integration site family (Wnt)/β-catenin pathway activation [8], making
LD abundance a marker of colorectal CSC. A LD-loaded phenotype has also been observed in
glioblastoma and in lung cancer where LD accumulation is associated to increased spheroid-forming
capacity [10]. In addition, metastatic potential of melanoma FEMX-1 cell line has been reported
to correlate with both CD133 and LD levels [11]. LD are organelles containing neutral lipids
(triglycerides and cholesteryl esters) surrounded by a phospholipid monolayer and coat proteins
named perilipins [12]. Lipolysis of LD contributes to cellular metabolism, however, LD may also
counteract lipotoxicity induced by potentially toxic intracellular fatty acid accumulation [13] or limit
potentially toxic reactive oxygen species levels [14], avoiding peroxidation of polyunsaturated fatty
acids[15]. Transcriptional activation of lipogenic genes such as Sterol Regulatory Element-Binding
Protein-1 (SREBP-1) and Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) may be involved
in LD accumulation. Their expression induces transdifferentiation of different cell types into
adipocyte-like cells, thus accumulating triglycerides within LD [16]. Triglycerides stored inside LD
may be hydrolyzed by cytosolic lipases or by lysosomal acidic lipases through the autophagic pathway.
Autophagy, a highly conserved mechanism originally described in yeast, allows the turnover of cellular
components and damaged organelles through double-membrane vesicles called autophagosomes,
which fuse with lysosomes enabling autophagic substrates degradation by lysosomal enzymes and
monomeric units recycle [16]. Mammalian Target Of Rapamycin (mTOR) is one of the main negative
autophagy regulators since it can phosphorylate factors essential for the process initiation, such as
UNC-51 Like Kinase (ULK1), leading to autophagy inhibition [17]. Conversely, AMP activated protein
kinase (AMPK) is a positive autophagy regulator; in fact, AMPK phosphorylation has been shown
to drive autophagy induction [18]. Under metabolic stress conditions, as a result of its activation,
AMPK induces autophagy for energy homeostasis through degradation of macromolecular nutrients,
such as glycogen and LD. During autophagy a cytosolic protein named microtubule-associated protein
1A/1B-Light Chain 3 (LC3-I) is processed to its phosphatidylethanolamine conjugate named LC3-II
and recruited to the autophagosomal membranes. LC3-II quantification represents a suitable way to
quantify autophagy since it increases under autophagy inducing conditions. When LD are sequestered
into autophagosomes for their lysosomal breakdown, lipids are mobilized through a specific form
of autophagy (also called lipophagy). Such process was originally described in hepatocytes, where
lipophagy has been implicated in the regulation of cellular lipid content [19], and has also been shown
in other cells types [20,21]. Remarkably, in clear cell renal cell carcinoma, lipophagy impairment leads
to LD accumulation in the cytoplasm and correlates with carcinoma development, associated to bad
prognosis [22].
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Altogether, these data suggest that LD are cytosolic structures which deserve to be better explored
in cancer models, as well as the cellular mechanisms associated to their accumulation. In the present
study, we addressed such issue focusing on an in vitro model of melanoma CSC. Many reports
demonstrate the CSC involvement in cancer initiation, progression and chemoresistance. Malignant
melanoma CSC, similar to other CSC, generate continuously growing tumor [23]. As a CSC model,
we used two cell lines established from human melanoma patients as previously described [2,24],
namely Mel1 and Mel3. These cells were cultured as less differentiated melanosphere-derived CSC
(MSC) and differentiating melanosphere-derived melanoma cells (PC).
We investigated the relationship between LD enrichment and autophagy. Interestingly, we found
higher LD accumulation in melanosphere-derived cells as compared to differentiating melanoma cells.
We also found differences between these cell types in the autophagic flux and in the activation of
molecular regulators upstream this process. We concluded that LD enrichment characterizes melanoma
CSC and that such LD-loaded phenotype correlates to autophagy down-regulation.
2. Results
2.1. Cells of Melanospheres Isolated from Metastatic Melanoma Display Abundant LD and Lipid Uptake as well
as Strong Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) and Sterol Regulatory Element-Binding
Protein-1 (SREBP-1) Expression
Lipogenic pathways are upregulated in different experimental cancer models, thus we
investigated the attitude to accumulate lipids within LD both in melanosphere-derived CSC (MSC)
and in melanosphere-derived early (PC-E) and late (PC-L) differentiating cells. We first analyzed the
stemness marker CD133 [25] protein expression by western blot in total cell lysates and found higher
level in MSC as compared to PC-E and PC-L as shown in Figure 1A. We then investigated if, similar to
colorectal cancer, CD133 expression level correlates with LD abundance [8]. To this aim, we stained
cells with Oil Red O, which allows selective detection of neutral lipids by light microscopy. MSC were
found to be mostly characterized by multiple LD occupying the entire cytoplasm, while differentiating
cells at either culture time, i.e., PC-E and PC-L, display moderate number or few LD mainly located
at the cell periphery (Figure 1B). Addition of exogenous fatty acids is known to further stimulate
LD formation [26]; we then investigated if LD staining in our experimental model increases upon
fatty acid addition. MSC, PC-E and PC-L were treated with oleic acid and Nile Red-stained neutral
lipids contained inside LD were quantified by flow cytometry. Higher fold elevation of neutral lipids
staining after oleic acid treatment was found in MSC as compared to PC-E and PC-L, as shown in
Figure 1C. Expression of transcription factors involved in lipid storage was then investigated. PPAR-γ
and SREBP-1 proteins have been associated with fatty droplets accumulation [27–29]. We found higher
level of both PPAR-γ and SREBP-1 in MSC as compared to PC-E and PC-L, as shown in Western blot
experiments (Figure 2). We therefore concluded that melanosphere-derived melanoma cells display
a lipid-storing phenotype.
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Figure 1. CD133 antigen (also known as prominin-1) expression and lipid-storing phenotype in 
melanosphere-derived cells. (A) CD133 marker is up-regulated in melanosphere-derived cancer stem 
cells (MSC). MSC and differentiating melanosphere-derived melanoma cells Early and Late (PC-E 
and PC-L) were lysed; protein samples were subjected to Western blot analyses and CD133 was 
detected. Western blot panel is representative of three independent experiments and reveal CD133 
progressive down-regulation in melanoma cells undergoing progressive differentiation. β-Actin was 
used as a loading control. Densitometric analyses of CD133 relative to β-Actin in three independent 
experiments are presented in the graph as the mean ± s.d. expressed as Arbitrary Units (AU). * 
indicates p ≤ 0.05vs. MSC; (B) Lipid Droplets (LD) staining is higher in MSC. MSC, PC-E and PC-L 
were stained with Oil Red O and then observed by bright-field microscopy. The images shown are 
representative of three independent experiments and reveal reduction in LD color intensity with 
melanoma cell differentiation. Bar corresponds to 35 μm; (C) MSC display increased lipid up-take. 
Increase of Nile Red (NR)-stained neutral lipids was evaluated by flow-cytometry after oleic acid 
treatment in MSC, PC-E and PC-L and reported in the graph as FL2 fluorescence fold increase vs. 
untreated cells. The data shown are the mean ± s.d. of three independent experiments. * indicates p ≤ 
0.05 vs. MSC. 
Figure 1. CD133 antigen (also know as promi i -1) expression and lipid-st ring phenotype in
melanosphere-derived cells. (A) CD133 marker is up-regulated in melanosphere-derived cancer
stem cells (MSC). MSC and iffer tiating m lanosphere-d rived melanoma cells Early and Late
(PC-E and PC-L) were lysed; protein samples were subjected to Western blot analyses and CD133 was
detected. Western blot panel is representative of three independent experiments and reveal CD133
progressive down-regul tion i melanoma cells undergoing ogressive differentiation. β-Actin was
used as a loading control. Densitometric analyses of CD133 relative to β-Actin in three independent
experiments are presented in the graph as the mean± s.d. expressed as Arbitrary Units (AU). * indicates
p ≤ 0.05 vs. MSC; (B) Lipi D oplets (LD) staining is higher in MSC. MSC, PC-E and PC-L were stained
with Oil Red O and then observed by bright-field microscopy. The images shown are representative
of three independent experiments and reveal re uction in LD color intensity with melanoma cell
differentiation. Bar corresponds to 35 µm; (C) MSC display increased lipid up-take. Increase of Nile
Red (NR)-stained neutral lipids was evaluated by flow-cytometry after oleic acid treatment in MSC,
PC-E and PC-L and reported in the graph as FL2 fluorescence fold increase vs. untreated cells. The data
shown are the mean ± s.d. of three independent experiments. * indicates p ≤ 0.05 vs. MSC.Int. J. Mol. 2017, 18, 1271 5 of 13 
 
 
Figure 2. MSC express higher PPAR-γ and SREBP-1 levels as compared to PC-E and PC-L. MSC, PC-
E and PC-L were lysed and protein samples were subjected to Western blot analyses using 
Glyceraldehyde 3-Phosphate Dehydrogenase (GAPDH) as a loading control. Representative panels 
of: PPAR-γ (A); and SREBP-1 (C) are shown. Densitometric analyses of: PPAR-γ (B); and SREBP-1 (D) 
relative to GAPDH in three independent experiments are presented in the graph as the mean ± s.d. 
expressed as Arbitrary Units (AU). PPAR-γ and SREBP-1 show down-regulation in melanoma cells 
undergoing progressive differentiation. * indicates p ≤ 0.05 in PC vs. MSC. 
2.2. MSC Display Lower Autophagic Flux as Compared to Differentiating Melanoma Cells 
LD have been shown to act as substrates of autophagy [19]. We then investigated if the different 
attitude to accumulate lipids in MSC as compared to PC-E and PC-L may correlate with a different 
autophagic flux, by measuring the membrane-bound LC3 (LC3-II) as previously reported [30]. LC3-II 
turnover may be too fast to be correctly assessed as expression change. Bafilomycin A1 has been 
reported to circumvent such problem [19]; it is an inhibitor of autophagosome and lysosome fusion, 
a late step of the process, and blocks LC3-II degradation and loss. Figure 3 shows that, upon 
bafilomycin A1 treatment, LC3-II level is lower in MSC as compared to PC-E and PC-L. We therefore 
concluded that differentiation of melanosphere-derived melanoma cells is associated to autophagic 
flux increase. 
Figure 2. MSC express higher PPAR-γ and SREBP-1 levels as compared to PC-E and PC-L. MSC, PC-E
and PC-L were lysed and protein samples were subjected to Western blot analyses using Glyceraldehyde
3-Phosphate Dehydrogenase (GA DH) as a loading control. Representative panels of: PPAR-γ (A);
and SREBP-1 (C) are shown. Densitometric analyses of: PPAR-γ (B); and SREBP-1 (D) relative to
GAPDH in three independent experiments are presented in the graph as the mean ± s.d. expressed
as Arbitrary Units (AU). PPAR-γ and SREBP-1 show dow -regulati n in melanoma cells undergoing
progressive differentiation. * indicates p ≤ 0.05 in PC vs. MSC.
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2.2. MSC Display Lower Autophagic Flux as Compared to Differentiating Melanoma Cells
LD have been shown to act as substrates of autophagy [19]. We then investigated if the different
attitude to accumulate lipids in MSC as compared to PC-E and PC-L may correlate with a different
autophagic flux, by measuring the membrane-bound LC3 (LC3-II) as previously reported [30]. LC3-II
turnover may be too fast to be correctly assessed as expression change. Bafilomycin A1 has been
reported to circumvent such problem [19]; it is an inhibitor of autophagosome and lysosome fusion,
a late step of the process, and blocks LC3-II degradation and loss. Figure 3 shows that, upon bafilomycin
A1 treatment, LC3-II level is lower in MSC as compared to PC-E and PC-L. We therefore concluded
that differentiation of melanosphere-derived melanoma cells is associated to autophagic flux increase.Int. J. Mol. 2017, 18, 1271 6 of 13 
 
 
Figure 3. LC3-II increases in melanoma cells undergoing progressive differentiation revealing 
autophagic flux up-regulation. (A) MSC, PC-E and PC-L were cultured in the presence or absence of 
the lysosomal degradation inhibitor bafilomycin A1 (BAF). They were lysed and protein samples 
were subjected to Western blot analysis. LC3-II increase in differentiated melanoma cells, although 
evident in either case, is more evident after BAF treatment, thus demonstrating autophagic flux up-
regulation as function of time of differentiation. Western blot panel is representative of three 
independent experiments. β-Actin was used as a loading control; (B) densitometric analysis of LC3-
II relative to β-Actin in three independent experiments is presented in the graph as the mean ± s.d. 
expressed as AU. BAF-treated MSC vs. untreated MSC display significant increase (p ≤ 0.05). Similarly, 
F treated PC-E vs. untreated PC-E display significant increase (p ≤ 0.05.** indicates p ≤ 0.05 in BAF-
treated PC vs. BAF-treated MSC. * indicates p ≤ 0.05 in untreated PC vs. untreated MSC. 
2.3. MSC Display Different AMPK and mTOR Phosphorylation as Compared to PC-E and PC-L 
Key regulators of the autophagy process were then analyzed to elucidate molecular players 
underlying the observed differences in autophagic flux. Autophagy is often induced by AMPK, thus 
we investigated AMPK activation in MSC and PC. The phosphorylation of AMPK isoform α in 
Thr172, which is involved in AMPK activation, was found to be higher in PC-E and PC-L as compared 
to MSC as shown in Figure 4A,B. 
We then investigated phosphorylation of mTOR in Ser2448 as a biomarker of mTORC complex-
1 activation, since autophagy is related to inactivation of mTOR complex-1. mTOR phosphorylation 
in Ser2448 was found to be reduced in PC-E and PC-L cells as compared to MSC (Figure 4C,D), further 
confirming increased autophagic flux in differentiating melanoma cells as compared to melanosphere 
cells. 
Figure 3. LC3-II increases in melano lls ndergoing progressive differentiation revealing
autophagic flux p-regulation. (A) MSC, PC-L were cultured in the presence or absence of
the lysosomal degradation inhibitor bafilomycin A1 (BAF). They were lysed and protein sa ples were
subjected to Western blot analysis. LC3-II increase in differentiated melanoma cells, although evident
in either case, is more evident after BAF treatment, thus demonstrating autophagic flux up-regulation
as function of time of differentiation. Western blot panel is representative of three independent
experiments. β-Actin was used as a loading control; (B) densitometric analysis of LC3-II relative to
β-Actin in three independent experiments is presented in the graph as the mean ± s.d. expressed as
AU. BAF-treated MSC vs. untreated MSC display significant increase (p ≤ 0.05). Similarly, BAF treated
PC-E vs. untreated PC-E display significant increase (p ≤ 0.05). ** indicates p ≤ 0.05 in BAF-treated PC
vs. BAF-treated MSC. * indicates p ≤ 0.05 in untreated PC vs. untreated MSC.
2.3. MSC Display Different AMPK and mTOR Phosphorylation as Compared to PC-E and PC-L
Key regulators of the autophagy process were then analyzed to elucidate molecular players
underlying the observed differences in autophagic flux. Autophagy is often induced by AMPK, thus
we investigated AMPK activation in MSC and PC. The phosphorylation of AMPK isoform α in Thr172,
which is involved in AMPK activation, was found to be higher in PC-E and PC-L as compared to MSC
as shown in Figure 4A,B.
We then investigated phosphorylation of mTOR in Ser2448 as a biomarker of mTORC complex-1
activation, since autoph gy is related to inactivation of mTOR omplex-1. mTOR phosphorylation
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in Ser2448 was found to be reduced in PC-E and PC-L cells as compared to MSC (Figure 4C,D),
further confirming increased autophagic flux in differentiating melanoma cells as compared to
melanosphere cells.Int. J. Mol. 2017, 18, 1271 7 of 13 
 
 
Figure 4. AMPK and mTOR phosphorylation levels change with melanoma cell differentiation. MSC, 
PC-E and PC-L were lysed and protein samples were subjected to Western blot using β-Actin or 
GAPDH as a loading control. Representative panels of P-AMPK and AMPK (A); and P-mTOR and 
m-TOR (C) are shown; (B,D) densitometric analyses of P-AMPK/AMPK and P-mTOR relative to the 
corresponding loading control, respectively, reveal progressive P-AMPK/AMPK increase and progressive 
P-mTOR decrease as function of time of differentiation. Data are presented as the mean ± s.d. expressed 
as AU of three independent experiments. * indicates p ≤ 0.05 in PC vs. MSC. 
2.4. LD Co-Localization with Autophagosomes in Melanoma Cells 
In order to further investigate autophagy involvement in LD clearance, all three cell types were 
treated with bafilomycin A1 and then analyzed by immunofluorescence of the autophagosome 
marker LC3 and perilipin, a protein involved in LD coating. Representative immunofluorescence 
experiments are shown in Figure 5. As reported, bafilomycin A1 inhibits autophagosome/lysosome 
fusion and is used to better appreciate autophagosome staining [30]. Upon bafilomycin A1 treatment, 
we observed, as expected, increased punctuated LC3 signal as compared to the controls in all three 
cell types, confirming western blot results shown in Figure 3A. Furthermore, we found a more 
frequent co-localization of perilipin and LC3 in PC-E and PC-L, as compared to MSC, after 
bafilomycin A1 treatment. These data indicate that LD clearance may be blocked by bafilomycin A1, 
supporting that it may occur at least in part via autophagic flux. This finding strongly suggests that 
LD loss may be the result of enhanced autophagy. 
Altogether, such data led us to hypothesize that higher LD accumulation observed in MSC 
(Figure 1B,C) may be the result of reduced autophagy found in MSC as compared to differentiating 
melanoma cells (Figures 3 and 4). 
  
i l ll if ,
and PC-L wer lysed and protein samples w re subjected to Western blot usingβ-Actin or GAPDH
as a loading control. Representative panels of P-AMPK and AMPK (A); and P-mTOR and m TOR (C) are
shown; B,D) densitometric analyses of P-AMPK/AMPK and P-mTOR relative to the corresponding
l ading control, respe tively, reveal progressive P-AMPK/AMPK increase and progressive P-mTOR
decrease as function of time of differentiation. D ta are presented as th mean ± s.d. expressed as AU
of three independent experiments. * indicates p ≤ 0.05 in PC vs. MSC.
r er to further investigate autophagy involvement in LD clearance, all three cell types
w re treated with bafilomycin A1 and then nalyzed by i munofluorescence of the
r t i i l i L coating. i fl
i . re orte , bafilo ycin A1 inhibits autophagosome/
tt i t bafil i tre t t,
r e , as expected, increased punctuated LC3 signal s compared to the controls in all three c ll
types, confirming western blot results shown in Figure 3A. Furthermore, we found a more frequent
co-localization of perilipin and LC3 in PC-E and PC-L, as compared to MSC, aft r bafilomycin A1
treatment. These d ta indicate that LD clear nce may be blocked by bafilomy in A1, supporting that it
may ccur at leas in part via utophagic flux. This finding strongly suggests that LD lo s may be the
result of enhanced autophagy.
Int. J. Mol. Sci. 2017, 18, 1271 7 of 12
Int. J. Mol. 2017, 18, 1271 8 of 13 
 
 
Figure 5.LC3-stained autophagosome spots co-localize with perilipin-stained LD suggesting LD 
clearance through autophagy. Immunofluorescence for perilipin (green) or LC3 (red) was performed 
on MSC, PC-E and PC-L, cultured in the absence (CTR) or presence of the lysosomal degradation 
inhibitor bafilomycin A1 (BAF). Yellow spots, indicating LC3-perilipin co-localization, increase as 
function of differentiation and are more evident in BAF-treated cells. Representative images of three 
experiments. All images were taken at the same magnification Bar corresponds to 60 μm. Insets 
correspond to further 5× enlargement. 
3. Discussion 
In the present study, we demonstrate a lipid storing-phenotype with lipid droplets (LD) 
accumulation in a stem cells melanoma model (MSC). LD are organelles involved in excess lipids 
storage and are surrounded by amphipathic lipids and coating proteins. We also show that such lipid 
storage is reduced in PC-E and PC-L, i.e., differentiated melanoma cells, and we relate such reduction 
to autophagy increase. 
LD enrichment has been previously described in colorectal cancer stem cells. These cells express 
CD133 and activate Wnt pathway; they show high LD levels [8] and this represents their specific 
morphological signature correlating with high tumorigenic potential. Interestingly, in MSC, we 
found, similar to colorectal cancer stem cells, a positive relation between CD133 expression and LD 
accumulation In addition to their function in cellular lipid homeostasis, LD seem to protect cancer 
cells from reactive oxygen species toxicity [31] as well as to be relevant in the temporary sequestration 
of proteins such as histones, enzymes involved in purine synthesis and viral capsids [32]. In different 
cancer models lipid storage has been reported as a possible consequence of hypoxia and related to 
fatty acid uptake [31]. Some transcription factors have been involved in LD biogenesis such as SREBP 
and PPAR, which regulate the expression of genes participating in fatty acid uptake and consequent 
lipid accumulation [33]. These findings have been confirmed by our study regarding higher 
expression of SREBP-1 and PPAR-γ in MSC and lower levels in the differentiating PC-E and PC-L. 
Since various saturated or unsaturated long-chain fatty acids such as linoleic and oleic acid are 
important sources for LD formation, the effect of oleic acid treatment was evaluated in our 
experimental model. We found that MSC display higher oleic acid uptake than PC-E and PC-L and 
this phenotype parallels with higher LD accumulation observed in MSC. 
Figure 5. LC3-stained autophagoso -localize with peril pin-stained LD suggesting LD
clearance through autophagy. Immunofluorescence for peril pin (gre (red) was performed on
MSC, PC-E and PC-L, cultured in the absence (CTR) or presence of the lysosomal degradation inhibitor
bafilomycin A1 (BAF). Yellow spots, indicating LC3-perilipin co-localization, increase as function of
differentiation and are more evident in BAF-treated cells. Representative images of three experiments.
All images were taken at the same magnification Bar corresponds to 60 µm. Insets correspond to further
5× enlargement.
3. Discussion
In the present study, we d monstrate a lipid storing-phenotype with lipid droplets (LD)
accumul tion in a stem cells melanoma model (MSC). LD are rganelles involved in excess lipids
storage and are surrounded by amphipathic lipids and coating proteins. We also show that such lipid
storage is reduced in PC-E and PC-L, i.e., differentiated melanoma cells, and we relate such reduction
to autophagy increase.
LD enrichment has been previously described in colorectal cancer stem cells. These cells express
CD133 and activate Wnt pathway; they show high LD levels [8] and this represents their specific
morphological signature correlating with high tumorigenic potential. Interestingly, in MSC, we
found, similar to colorectal cancer stem cells, a positive relation be ween CD133 expression a d LD
accumulation In addition t their functio in c llular lipid hom o tasis, LD seem to protect cancer cells
from reactive oxygen species toxicity [31] as well as t be relevant in the tem rary sequestration of
proteins such as histones, enzymes involved in purine synthesis and viral capsids [32]. In different
cancer models lipid storage has been reported as a possible consequence of hypoxia and related to
fatty acid uptake [31]. Some transcription factors have been involved in LD biogenesis such as SREBP
and PPAR, which regulate the expression of genes participating in fatty acid uptake and consequent
lipid accumulation [33]. These findings have been confirmed by our study regarding higher expression
of SREBP-1 and PPAR-γ in MSC and lower levels in the differentiating PC-E and PC-L. Since various
saturated or unsaturated long-chain fatty acids such as linoleic and oleic acid are important sources for
LD formation, the effect of oleic acid treatment was evaluated in our experimental model. We found
that MSC display higher oleic acid uptake than PC-E and PC-L and this phenotype parallels with
higher LD accumulation observed in MSC.
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On the other hand, LD degradation has been shown to be autophagy-related [20]. Autophagy
may therefore clear LD and mobilize their accumulated lipids but the relative contribution of this
pathway to lipolysis in cancer stem cell models has never been investigated. In the present study
we addressed this issue and found that an increase of autophagic flux, evaluated through LC3-II
level analysis in the presence or absence of bafilomycin A1, parallels the reduction of LD storage
during melanoma stem cells differentiation. Such autophagy increase in PC as compared to MSC
has also been confirmed by evaluating the phosphorylation level of proteins involved in autophagic
activity (i.e., AMPK and mTOR) whose modulation depending on the differentiation level was found
to correlate with autophagy stimulation.
According to our hypothesis, autophagy might be involved in LD degradation in PC, thus
explaining reduced LD staining. Consistently with this, we found co-localization between LC3
stained autophagosomes spots and perilipin dots, particularly when autophagic flux is blocked by
bafilomycin A1 treatment and in differentiating PC, indicating LD uptake into autophagosomes
obtained in different experimental models, for instance in hepatocytes, where autophagy has been
demonstrated to be responsible for LD degradation [20]. Remarkably, in hepatocytes, a bidirectional
relation has been shown between autophagy and lipid stores. In fact, hepatic lipid accumulation has
been demonstrated to decrease autophagic activity in high fat diet-fed mouse liver. In this model,
a defect in autophagosome/lysosome fusion, possibly due to lipid alterations in autophagosomes or
lysosomes, leads to increased lipid retention [19,20]. We are currently further investigating this issue
in MSC.
The role of autophagy in cancer is quite debated. Thanks to its ability to recycle cellular
components it has been considered a mechanism favoring cancer cells, which generally have higher
energy requirements than normal counterparts. On the other hand, defects in autophagic genes
have been linked with increased tumorigenesis, thus supporting its tumor-suppressing function [34].
The present manuscript describes a relation between lipid-storing phenotype, autophagic flux level
and melanoma stem cells differentiation, and provides indications suggesting that autophagy may
be involved in melanoma stem cells biology. The role of autophagy in regulating pluripotency and
differentiation of CSC is largely unknown. A recent study by Sharif and collaborators [35] demonstrates
that a basal level of autophagy is crucial for the pluripotency of CSC (embryonal carcinoma cells (ECC))
and that increase or decrease in this autophagy basal level forces CSC toward differentiation and
senescence. Moreover, the interplay between autophagy and differentiation has been also underlined
in MCF-7 breast cancer cells [36] where autophagy activation is strictly linked to loss of mitotic and
metastatic potential. Further studies are ongoing in order to investigate if, similar to ECC cells,
an accurate modulation of autophagy basal level may maintain MSC in an undifferentiated state and
interfere with their differentiation.
Our results support a novel role for fatty acid and lipid storage/recycling mechanisms in cancer
cell stemness and cell destiny as suggested in recent studies involving other models. As recently
pointed out, molecular mechanisms promoting LD accumulation have not been described yet in cancer
cells, while LD biogenesis appears to have a key role in tumorigenesis [37]. The role of lipids in
autophagy control is currently under investigation; remarkably LC3 lipidation has been identified as
one of the key steps of autophagosome formation to control autophagosome membranes kinetics [38].
We believe the present study reveals novel mechanisms by which lipids and lipid intake relate with
stem cell fate.
4. Materials and Methods
4.1. Cell Cultures
Data of the present study were collected from melanosphere-derived human melanoma cells and
from two differentiating stages of melanosphere-derived human melanoma cells.
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More in detail, melanoma CSC, namely Mel1 CSC, were obtained by surgical specimens as
previously described and cultured as less differentiated melanospheres (MSC) in stem cell medium [2].
Briefly, after washing surgical specimens several times, their tissue dissociation was carried out.
Recovered cells were cultured on flasks non-treated for tissue culture in order to reduce cell adherence and
support their growth within undifferentiated tumor-spheres. Serum-free medium containing 50 µg/mL
insulin, 100 µg/mL apo-transferrin, 10 µg/mL putrescine, 0.03 µM sodium selenite, 2 µM progesterone,
0.6% glucose, 5 mM HEPES, 0.1% sodium bicarbonate, 0.4% BSA, glutamine and antibiotics, dissolved in
DMEM-F12 medium (Gibco-Invitrogen, Carlsbad, CA, USA) and supplemented with 20 ng/mL EGF
and 10 ng/mL bFGF was used. It was replaced twice a week until cells started to grow forming floating
aggregates. More-differentiated cells (PC) were obtained by growing melanospheres in Melanocyte
Growth Medium (MGM4, Lonza, East Rutherford, NJ, USA) for 4 days (PC early, PC-E) or 8 days
(PC late, PC-L). In PC-L cultures, growth medium was changed after four days.
Additional experiments were carried out on another melanoma-propagating cell line, namely Mel3.
Oleic acid (Sigma-Aldrich, Milano, Italy) 400µM was incubated for 24 h. Bafilomycin A1
(Sigma-Aldrich) 100 nM was added 4 h before cell harvesting.
4.2. Oil Red O Staining
Briefly, a stock oil red solution was prepared diluting 0.7 g Oil Red O with 200 mL isopropanol.
A working dilution was then obtained by mixing 6 parts Oil Red O stock with 4 parts dH2O. MSC were
harvested, smeared on slides by cytospin centrifugation. Cells were fixed with 10% formalin 5 min
at room temperature. Then fresh formalin was added and incubated 1 h. After formalin removal,
cells were washed with 60% isopropanol 5 min at room temperature. After isopropanol removal,
oil red working solution was added for 10 min. Cells were then washed with H2O and analyzed
immediately by light microscopy. The Axioskop 2 plus microscope (Carl Zeiss Microimaging, Inc.,
Milan, Italy) was used. Images were obtained at room temperature using AxioCamHRC camera
(Carl Zeiss Microimaging, Inc.) by Axiovision software (version 3.1, Carl Zeiss Microimaging, Inc.).
4.3. Lipid Determination by Flow Cytometry
Lipid content was assessed by multi-parameter flow cytometry, in association with fluorescent
dye Nile Red (NR) using Lipid Droplets Fluorescence Assay Kit (Cayman, Ann Arbor, MI, USA). Cells
were stained with NR according to producer’s instructions. The NR fluorescence was determined
using CyAn ADP flow cytometer equipped with a 488 nm, 20mW semiconductor laser. Upon excitation
by the 488 nm laser, NR emits at 580 nm when dissolved in neutral lipids [39] which are detected by
the FL2 (575/25) emission. For each sample, 150,000 cells were analyzed. Flow cytometry data were
analyzed using the DeNovo Software FCS Express5.0 (DeNovo, Glendale, CA, USA).
4.4. Immunoblotting
Immunoblot analysis was carried out as previously described [40]. Membranes were probed
using the following antibodies: anti-CD133 (Biorbyt, Cambridge, UK), anti-SREBP-1 and anti-GAPDH
(Santa Cruz, Heidelberg, Germany), anti-p62 (Abcam, Cambridge, UK), anti-β-Actin-HRP
(Sigma-Aldrich, Milano, Italy), anti-mTOR, anti-P-mTOR (Ser2448), anti-AMPK, anti-P-AMPK
(Thr172), anti-LC3, anti-PPAR-γ (Cell Signaling, Danvers, MA, USA). Secondary antibodies were
horseradish peroxidase-conjugated goat anti-mouse or anti-rabbit (Bio-Rad, Hercules, CA, USA).
PVDF membranes (Amersham Bioscience, Piscataway, NJ, USA) were used for anti-LC3 immunoblot.
Nitrocellulose membranes (Amersham Bioscience) were probed with all other antibodies.
4.5. Immunofluorescence
For immunofluorescence experiments, slides were prepared as described [41–43]. Briefly, MSC,
PC-E and PC-L, were gently resuspended and laid on poly-lysine coated slides for 3 min at 37 ◦C.
Cells were fixed for 10 min at room temperature with 4% paraformaldehyde (Sigma), permeabilized
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for 10 min with HEPES-buffered PBS (Sigma) containing 0.1% saponin (Sigma) and 3% BSA (Sigma),
and stained with anti-LC3 mAbs (Nanotools, Teningen, Germany) and anti-perilipin (Cell Signaling),
followed by goat anti-mouse isotype-specific Ab or goat anti-rabbit Ab labeled with Alexa Fluor 555
and 488 (Invitrogen), respectively. Slides were analyzed using a Leica laser confocal microscope
TCS SP2 [44]. Images were processed with ImageJ software (open platform developed at NIH,
Bethesda, MD, USA for scientific image analysis, https://imagej.nih.gov/ij/) and Leica LAS AF
Lite software (version 4.0, Leica Microsystems, Milan, Italy, http://downloads.informer.com/leica-las-
af-lite/download/).
4.6. Data Handling and Statistical Analysis
All experiments were performed at least three times. Data collected were averaged and expressed
as mean ± standard deviation (s.d.). Unpaired two-tailed student’s t-test was carried out and
significance was set at p ≤ 0.05.
5. Conclusions
The present manuscript demonstrates an inverse relationship between lipid-storing phenotype
and melanoma stem cells differentiation, providing novel indications involving autophagy in
melanoma stem cells biology.
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